| Parameter | Score |
|---|---|
| 1. Scale | A |
| 2. Study Population | A |
| 3. Samples | A |
| 4. Measurand | A |
| 5. Pre-Analytical | A |
| 6. Replicate Analysis | A |
| 7. Steady State | A |
| 8. Outlier Analysis | B |
| 9. Normality | B |
| 10. Variance Homogeneity | C |
| 11. ANOVA | A |
| 12. CI | C |
| 13. No of Results | C |
| 14. Concentrations | B |
| 15. Total Score | C10,12,13 |
| Comment |
| Parameter | Score |
|---|---|
| Matrix | Serum |
| Measurand | Cyfra21-1 |
| Unit | ug / L |
| Overall Analytical Principle Method | Immunoassay; Competitive |
| Number of Subjects | 30 |
| Number of Subjects included in BV estimation | 30 |
| Ethinicity | Caucasian |
| Age Mean / Median | 61.1 |
| Age Min | |
| Age Max | |
| Age SD | |
| Number of Males | 30 |
| Number of Females | |
| State of Well Being |
Non-healthy (excl pregnant)
|
| Diseases | |
| Study Duration Length | 6 |
| Study Duration Units | Month |
| Sampling Intervals, e.g. X sample(s) per Interval Unit | 4 |
| Interval Units | Year |
| Sampling Times | Start Time:
End Time: |
| Number of Samples | 4 |
| Average Number of Samples Used for BV Estimation | |
| Average Number of Replicates | 1.0 |
| Estimates of CVi | 22.5 |
| Calculated Confidence Intervals of CVi | Lower: 19.63, Upper: 26.37 |
| Estimates of CVg | 38.1 |
| Calculated Confidence Intervals of CVg | Lower: 29.64, Upper: 51.89 |
| Analytical CV | 1.8 |
| Calculated Confidence Intervals of Analytical CV | Lower: 1.29, Upper: 2.97 |
| Measurand Mean | |
| Measurand Min | |
| Measurand Max | |
| Measurand SD |